INVO BIOSCIENCE INC (OTCMKTS:IVOB) Reports Increase in Sellers; Strong Momentum for Short Players

INVO Bioscience, Inc. (OTCMKTS:IVOB) Logo

The stock of INVO BIOSCIENCE INC (OTCMKTS:IVOB) registered an increase of 300% in short interest. IVOB’s total short interest was 14,800 shares in September as published by FINRA. Its up 300% from 3,700 shares, reported previously. With 78,800 shares average volume, it will take short sellers 0 days to cover their IVOB’s short positions.

It closed at $0.299 lastly. It is up 0.00% since September 13, 2018 and is . It has by 0.00% the S&P500.

INVO Bioscience, Inc., a medical device company, provides novel solutions in assisted reproductive technologies to the reproductive health care community in the United States, Canada, South and Central America, Latin America, India, the Middle East, and Africa. The company has market cap of $46.51 million. The firm offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It currently has negative earnings. It also offers INVO procedure, an alternative infertility treatment that enables the conception and embryo development inside the womanÂ’s body.

Another recent and important INVO Bioscience, Inc. (OTCMKTS:IVOB) news was published by Seekingalpha.com which published an article titled: “INVO Bio out-licenses INVOcell fertility treatment in U.S. to Ferring Pharma; shares up 1% – Seeking Alpha” on November 13, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.